Putrescine

Putrescine

SCHEMBL5145556

NCCCCN.NCCCN

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.88
DNM1 Q05193 9/20 0.78
CA12 O43570 3/20 0.78
CA1 P00915 3/20 0.78
CA2 P00918 3/20 0.78
CA3 P07451 3/20 0.78
CA4 P22748 3/20 0.78
CA6 P23280 3/20 0.78
CA5A P35218 3/20 0.78
CA7 P43166 3/20 0.78
CA9 Q16790 3/20 0.78
CA14 Q9ULX7 3/20 0.78
CA5B Q9Y2D0 3/20 0.78
TSHR P16473 3/20 0.78
LMNA P02545 1/20 0.78
BLM P54132 1/20 0.78
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 1/20 0.50
EPHX1 P07099 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Putrescine SCHEMBL7599194 0.94 NFKB1 (0.78) NFKB1DNM1CA12CA1CA2
SCHEMBL5718543 0.94 DNM1 (0.89) NFKB1DNM1CA12CA1CA2
SCHEMBL29160873 0.94 DNM1 (0.89) NFKB1DNM1CA12CA1CA2
Putrescine SCHEMBL21642 0.94
SCHEMBL7267804 0.94 NFKB1 (0.75) NFKB1DNM1CA12CA1CA2
SCHEMBL16345592 0.94 NFKB1 (0.75) NFKB1DNM1CA12CA1CA2
Putrescine SCHEMBL160836 0.94 NFKB1 (1.00) NFKB1DNM1CA12CA1CA2
SCHEMBL8182 0.94
SCHEMBL25350595 0.88
Putrescine SCHEMBL22227753 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070006775-A1 Method for producing a wet-laid fiber mat OWENS CORNING INTELLECTUAL CAPITAL, LLC 2007-01-11 US claimed
EP-0315027-A2 Amide-ester block copolymers and process for the preparation thereof GENERAL ELECTRIC COMPANY (US) 1989-05-10 EP claimed
US-20240199648-A1 MAP4K1 INHIBITORS BLUEPRINT MEDICINES CORPORATION 2024-06-20 US disclosed
EP-4305041-A1 MAP4K1 INHIBITORS Blueprint Medicines Corporation (US) 2024-01-17 EP disclosed
CN-117295748-A MAP4K1 inhibitors 缆图药品公司 2023-12-26 CN disclosed
CN-114477206-B Modification method of Ti-containing heteroatom molecular sieve 中国石油化工股份有限公司 2023-05-05 CN disclosed
WO-2022192145-A1 MAP4K1 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2022-09-15 WO disclosed
EP-3157978-B1 STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS SYMO CHEM B V (NL) 2021-08-11 EP disclosed
CN-112840021-A Compounds for stabilizing hydrolases in liquids 巴斯夫欧洲公司 2021-05-25 CN disclosed
US-10556994-B2 Strictly segmented thermoplastic elastomers as biodegradable biomaterials SYMO-CHEM B.V. (NL) 2020-02-11 US disclosed
US-20180334543-A1 STRICTLY SEGMENTED THERMOPLASTIC ELASTOMERS AS BIODEGRADABLE BIOMATERIALS SYMO-CHEM B.V. (NL) 2018-11-22 US disclosed
EP-0469331-A1 Process for preparing organic esters and amides and catalyst system therefor MONTELL NORTH AMERICA INC. (US) 1992-02-05 EP disclosed
EP-0468289-A2 Profiled emulsion polymers, especially for water and aqueous solution developable, photopolymerizable recording material BASF Aktiengesellschaft (DE) 1992-01-29 EP disclosed
US-4810436-A PREPARED FROM DECABORANE AND AN AMINE OR PHOSPHINE HOECHST CELANESE CORP. (US) 1989-03-07 US disclosed
EP-0231002-A2 Crosslinkable solid rubbery polymers BASF Aktiengesellschaft (DE) 1987-08-05 EP disclosed
US-4578284-A FROM DIMER ACID HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1986-03-25 US disclosed
US-4271284-A Process for the production of poly(amine allyl halide halohydrin silicate) copolymer and their reaction products BLOUNT DAVID H 1981-06-02 US disclosed
US-4235686-A POLYURETHANE, UNSATURATED POLYESTER, AND ETHYLENICALLY UNSATURATED MONOMER IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-11-25 US disclosed
US-4205155-A Process for the production of poly(allyl halide amine silicate) reaction products BLOUNT DAVID H 1980-05-27 US disclosed
US-4157438-A Process for the production of poly(amine allyl halide) copolymer and their reaction products BLOUNT DAVID H 1979-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199648-A1 MAP4K1 INHIBITORS MAP4K1, MAP4K4, MAP4K2 NFKB1 515/4885DNM1 2516/4885CA12 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.